0HCK Stock Chart & Stats
$159.24
-$0.11(-0.06%)
At close: 4:00 PM EDT
$159.24
-$0.11(-0.06%)
Day’s Range― - ―
52-Week Range$130.50 - $200.37
Previous CloseN/A
Volume2.00
Average Volume (3M)469.00
Market Cap
$10.91B
Enterprise Value$11.08B
Total Cash (Recent Filing)$1.14B
Total Debt (Recent Filing)$112.30M
Price to Earnings (P/E)22.3
Beta1.00
Next Earnings
Feb 03, 2027EPS Estimate
3.09Next Dividend Ex-DateN/A
Dividend Yield0.08%
Share Statistics
EPS (TTM)6.88
Shares Outstanding71,039,850
10 Day Avg. Volume409
30 Day Avg. Volume469
Financial Highlights & Ratios
PEG Ratio51.77
Price to Book (P/B)2.80
Price to Sales (P/S)2.81
P/FCF Ratio23.08
Enterprise Value/Market Cap1.02
Enterprise Value/Revenue2.66
Enterprise Value/Gross Profit3.94
Enterprise Value/Ebitda14.88
Forecast
1Y Price Target
$193.40Price Target Upside21.45% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering13
EPS Forecast (FY)11.21
Revenue Forecast (FY)$4.15B
Bulls Say, Bears Say
Bulls Say
Conservative Balance SheetVery low leverage gives Align substantial financial flexibility and resilience across the next several quarters. The modest debt burden reduces refinancing and interest pressure, while growing equity supports continued investment in innovation, operating improvements, and shareholder returns.
Digital Platform ExpansionA growing iTero installed base strengthens Align’s integrated digital workflow spanning scanning, treatment planning, Invisalign, exocad, and practice software. Greater platform adoption can deepen provider relationships and create recurring opportunities for additional cases and broader dental applications.
Growth And Margin ImprovementManagement’s multi-year framework points to continued volume expansion and operating leverage rather than reliance on a single quarter. Planned margin improvement, record doctor submitters, and better utilization could strengthen earnings power while supporting reinvestment in the platform.
Bears Say
Clear Aligner ASP PressurePersistent ASP pressure can limit revenue growth even when case volumes increase. Lower-priced geographic and product mix, discounts, and touch-up cases may constrain gross-margin expansion and require continued productivity gains to preserve profitability.
Discretionary Demand WeaknessClear aligner treatment is exposed to discretionary healthcare spending, so a prolonged soft consumer backdrop could restrain case starts and utilization. The company’s assumption of no recovery into 2027 indicates demand weakness may remain a durable growth constraint.
Systems And Services ContractionDeclining Systems and Services revenue weakens the contribution from scanners and related digital offerings, which are important to Align’s broader workflow strategy. A mix toward lower-priced and flexible acquisition models may also make recovery and margin improvement more difficult.
Align Tech News
0HCK FAQ
What was Align Tech’s price range in the past 12 months?
Align Tech lowest share price was $130.50 and its highest was $200.37 in the past 12 months.
What is Align Tech’s market cap?
Align Tech’s market cap is $10.91B.
When is Align Tech’s upcoming earnings report date?
Align Tech’s upcoming earnings report date is Feb 03, 2027 which is in 97 days.
How were Align Tech’s earnings last quarter?
Align Tech released its earnings results on Oct 28, 2026. The company reported $2.8 earnings per share for the quarter, beating the consensus estimate of $2.767 by $0.033.
Is Align Tech overvalued?
According to Wall Street analysts Align Tech’s price is currently Undervalued.
Does Align Tech pay dividends?
Align Tech pays a Notavailable dividend of $0.285 which represents an annual dividend yield of 0.08%. See more information on Align Tech dividends here
What is Align Tech’s EPS estimate?
Align Tech’s EPS estimate is 3.09.
How many shares outstanding does Align Tech have?
Align Tech has 71,039,850 shares outstanding.
What happened to Align Tech’s price movement after its last earnings report?
Align Tech reported an EPS of $2.8 in its last earnings report, beating expectations of $2.767. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of Align Tech?
Currently, no hedge funds are holding shares in GB:0HCK
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Align Tech Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$193.40 (21.45% Upside)
$193.40 (21.45% Upside)
Blogger Sentiment
Bullish
GB:0HCK Sentiment 67%
Sector Average 65%
Sector Average 65%
News Sentiment
Very Bearish
Bullish news 0%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
15.38%
12-Months-Change
Fundamentals
Return on Equity
11.76%
Trailing 12-Months
Asset Growth
4.61%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Align Tech
Align Technology, Inc. is a medical technology enterprise that develops, produces, and markets its leading products: Invisalign transparent dental aligners and iTero digital intraoral scanners, along with related services. These offerings serve a wide range of dental professionals, including orthodontists, general dentists, and those specializing in restorative and cosmetic dentistry. The company's operations are divided into two main business units: "Clear Aligner" and "Scanners and Services." The Clear Aligner segment offers a variety of solutions. Its comprehensive products include the full Invisalign treatment for teenage patients, designed to address complex orthodontic needs such as mandibular advancement, patient compliance tracking, and managing tooth eruption. It also features specialized Invisalign First Phase I and Phase 2 packages for younger children, typically aged seven to ten, who have mixed dentition (a combination of primary and permanent teeth). Beyond these, the segment provides non-comprehensive aligner options like Invisalign moderate, lite, express, and Invisalign Go. Additional non-case products include retention devices, fees for Invisalign training, and sales of ancillary items such as cleaning materials and adjustment tools used by dental practitioners during treatment. The Scanners and Services segment centers around the iTero scanner, a unified hardware platform offering various software applications for both restorative and orthodontic procedures. It supplies specialized restorative software to general dentists, prosthodontists, periodontists, and oral surgeons, as well as distinct software for orthodontists to manage digital patient records, perform diagnoses, and facilitate the fabrication of printed models and retainers. This segment also provides computer-aided design and manufacturing (CAD/CAM) services, along with supplementary products like disposable covers for the scanner wand and iTero models and dies. Furthermore, it includes third-party scanners and digital scan solutions, the Invisalign Outcome Simulator (a chair-side and cloud-based application for the iTero scanner), the Invisalign Progress Assessment tool, and TimeLapse technology, which enables clinicians to compare a patient's historical 3D scans against current data. Align Technology distributes its products worldwide, with a strong presence in the United States, Switzerland, and China. Founded in 1997, the company is headquartered in Tempe, Arizona.
0HCK Company Deck
0HCK Earnings Call
Q3 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call was positive overall. Align reported record Clear Aligner shipments and doctor submitters, broad international growth, improved utilization, stronger operating margins, healthy cash generation and continued investment in digital workflows and 3D-printing innovation. These strengths outweighed the lowlights, which included a challenging consumer environment, lower Systems and Services revenue, ASP and mix pressure, North American GP retail weakness, foreign exchange effects and reduced fourth-quarter revenue assumptions.View all GB:0HCK earnings summaries0HCK Revenue Breakdown
80.43% Clear Aligner
19.57% Systems and Services

0HCK Stock 12 Month Forecast
All Analysts
Top Analysts
Average Price Target
$193.40
▲(21.45% Upside)
Technical Analysis
1 Day
3 Days
1 Week
1 Month
Koninklijke Philips
―
Varex Imaging
―
InMode
―
Butterfly Network
―
GE Healthcare Technologies Inc
―









